fbpx

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2020 and Provide a Corporate Strategic Update

Conference Call to be Held on May 14, 2020 RANCHO CORDOVA, Calif., May 7, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2020 … Continued

ThermoGenesis and ImmuneCyte Joint Venture Developing Several Convalescent Plasma and Antibody Therapeutic Approaches Against COVID-19, Featured on FOX40 and Other Local News Outlets

RANCHO CORDOVA, Calif., April 24, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on multiple new outlets, including a Fox40 news segment titled, “Rancho Cordova Company Says It’s Working on Potential Treatment for Coronavirus,” regarding … Continued

ThermoGenesis Receives Acknowledgement Letter from FDA Allowing Its SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit for Distribution

RANCHO CORDOVA, Calif., April 16, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that on Wednesday April 15th, following submission of notification to the U.S. Food and Drug Administration (FDA), the Company has received the necessary acknowledgement letter which … Continued

ThermoGenesis Announces Its ImmuneCyte Joint Venture Acquires Key Technologies to Develop Fully Human Polyclonal and Monoclonal Antibody Therapeutics for COVID-19

RANCHO CORDOVA, Calif., April 13, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that its joint venture, ImmuneCyte Life Sciences, Inc., has completed the acquisition of worldwide intellectual property for developing fully human antibody therapeutics for COVID-19. The acquired … Continued

ThermoGenesis and ImmuneCyte’s Rapid COVID-19 Testing Kit Featured on Local CBS News Titled: “Different Kind of Coronavirus Test”

RANCHO CORDOVA, Calif., April 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was featured on a CBS 13 news segment titled, “Different Kind of Coronavirus Test”, regarding the Company’s SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit … Continued

ThermoGenesis’ Rapid COVID-19 Serological Test Kit Featured on FOX40 News Story Titled: “Rancho Cordova Company Develops Antibody Test to Detect COVID-19 in Minutes”

ThermoGenesis’ Rapid COVID-19 Serological Test Kit Featured on FOX40 News Story Titled: “Rancho Cordova Company Develops Antibody Test to Detect COVID-19 in Minutes”  RANCHO CORDOVA, Calif., April 2, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it was … Continued

© 2020 ThermoGenesis Corp.
How may we help?